semaglutide news november 2025 ESC 2025: Novo Nordisk's Wegovy superior to Zepbound in reducing CV events Impact of Semaglutide on Cirrhosis

Nicolau J, Nadal A, Sanchs P, Pujol A, Masmiquel L, Nadal C

Improved glucose stability Because GLP-1 medications were originally developed for type 2 diabetes, there is evidence from clinical trials to indicate their positive effect on glucose stability, at even lower doses than those needed for maximal weight loss

Yksek dozlarda potansiyel kalp ritmi bozukluu riski gibi konular iin yeterli veri yoktur

If you become pregnant or are planning to conceive, you must discontinue the medication and notify your doctor immediately

Semaglutide is a long-acting glucagon-like peptide 1 (GLP-1) agonist, while tirzepatide is both a GLP-1 agonist and a glucose dependent insulinotropic polypeptide (GIP)